#VectorBuilder #Sartorius #Biopharmaceutical

VectorBuilder and Sartorius Collaborate for Biopharmaceutical Innovation

On November 26, 2024, in a landmark announcement, VectorBuilder, a preeminent name in gene delivery services, joined forces with Sartorius, a renowned global partner in life sciences, to initiate a strategic cooperation agreement. This partnership is set to explore and innovate in the realm of gene vectors and mRNA bioprocess solutions, enhancing the pace and effectiveness of biopharmaceutical developments.

Over the years, both organizations have laid a strong foundation for collaboration, and this new agreement marks an expansion into more complex and innovative areas of research and application. Goals include co-developing innovative downstream processes specifically designed for cell and gene therapies. Furthermore, the partnership aims to optimize the platforms used for the commercial production of GMP-compliant mRNA, plasmid DNA, and viral vectors. Sustainability is a core focus, nurturing an environment where both firms will actively exchange knowledge and train personnel to elevate the biopharmaceutical sectors comprehensively.

Sarah Wang, Sartorius' Head of China, highlighted their dedication to customer-centric innovation, which drives their service and product evolution.